These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30584543)

  • 41. Multifaceted roles of adiponectin in rheumatoid arthritis.
    Liu D; Luo S; Li Z
    Int Immunopharmacol; 2015 Oct; 28(2):1084-90. PubMed ID: 26307192
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis.
    Mahmoudi M; Aslani S; Fadaei R; Jamshidi AR
    Int J Rheum Dis; 2017 Mar; 20(3):287-297. PubMed ID: 28205331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflammatory markers in patients with rheumatoid arthritis.
    Shrivastava AK; Singh HV; Raizada A; Singh SK; Pandey A; Singh N; Yadav DS; Sharma H
    Allergol Immunopathol (Madr); 2015; 43(1):81-7. PubMed ID: 24656623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
    Joosten LA; Radstake TR; Lubberts E; van den Bersselaar LA; van Riel PL; van Lent PL; Barrera P; van den Berg WB
    Arthritis Rheum; 2003 Feb; 48(2):339-47. PubMed ID: 12571842
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study.
    Ajeganova S; de Faire U; Jogestrand T; Frostegård J; Hafström I
    J Rheumatol; 2012 Jun; 39(6):1146-54. PubMed ID: 22589258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease.
    Cheng KH; Chu CS; Lee KT; Lin TH; Hsieh CC; Chiu CC; Voon WC; Sheu SH; Lai WT
    Int J Obes (Lond); 2008 Feb; 32(2):268-74. PubMed ID: 17878891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gaps in Addressing Cardiovascular Risk in Rheumatoid Arthritis: Assessing Performance Using Cardiovascular Quality Indicators.
    Barber CE; Esdaile JM; Martin LO; Faris P; Barnabe C; Guo S; Lopatina E; Marshall DA
    J Rheumatol; 2016 Nov; 43(11):1965-1973. PubMed ID: 27481908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti-High-Density Lipoprotein Antibodies in Patients With Rheumatoid Arthritis: Potential Implications for Cardiovascular Disease.
    Rodríguez-Carrio J; López-Mejías R; Alperi-López M; López P; Ballina-García FJ; González-Gay MÁ; Suárez A
    Arthritis Rheumatol; 2016 Jun; 68(6):1367-76. PubMed ID: 26815637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence that cytokines play a role in rheumatoid arthritis.
    Brennan FM; McInnes IB
    J Clin Invest; 2008 Nov; 118(11):3537-45. PubMed ID: 18982160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis.
    Andrés Cerezo L; Šumová B; Prajzlerová K; Veigl D; Damgaard D; Nielsen CH; Pavelka K; Vencovský J; Šenolt L
    Arthritis Res Ther; 2017 Apr; 19(1):79. PubMed ID: 28446208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of TNF-α with a focus on rheumatoid arthritis.
    Moelants EA; Mortier A; Van Damme J; Proost P
    Immunol Cell Biol; 2013 Jul; 91(6):393-401. PubMed ID: 23628802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of Adipocytokines in Coronary Atherosclerosis.
    Liberale L; Bonaventura A; Vecchiè A; Casula M; Dallegri F; Montecucco F; Carbone F
    Curr Atheroscler Rep; 2017 Feb; 19(2):10. PubMed ID: 28185154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis.
    Qi J; Ye X; Ren G; Kan F; Zhang Y; Guo M; Zhang Z; Li D
    Mol Immunol; 2014 Feb; 57(2):59-65. PubMed ID: 24091292
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: Current status and future directions.
    Ganesan R; Rasool M
    Int Rev Immunol; 2017 Jan; 36(1):20-30. PubMed ID: 28102734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome.
    Dudics S; Langan D; Meka RR; Venkatesha SH; Berman BM; Che CT; Moudgil KD
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Constitutive Activation of Integrin α9 Augments Self-Directed Hyperplastic and Proinflammatory Properties of Fibroblast-like Synoviocytes of Rheumatoid Arthritis.
    Emori T; Hirose J; Ise K; Yomoda JI; Kasahara M; Shinkuma T; Yoshitomi H; Ito H; Hashimoto M; Sugahara S; Fujita H; Yamamoto N; Morita Y; Narumiya S; Aramori I
    J Immunol; 2017 Nov; 199(10):3427-3436. PubMed ID: 29038247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular risk and rheumatoid arthritis--the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation.
    Kozera L; Andrews J; Morgan AW
    Rheumatology (Oxford); 2011 Nov; 50(11):1944-54. PubMed ID: 21752870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pattern-recognition receptor nucleotide-binding oligomerization domain--containing protein 1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts.
    Yokota K; Miyazaki T; Hemmatazad H; Gay RE; Kolling C; Fearon U; Suzuki H; Mimura T; Gay S; Ospelt C
    Arthritis Rheum; 2012 May; 64(5):1329-37. PubMed ID: 22143988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis.
    Filková M; Vernerová Z; Hulejová H; Prajzlerová K; Veigl D; Pavelka K; Vencovský J; Šenolt L
    Cytokine; 2015 May; 73(1):36-43. PubMed ID: 25697137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Emerging Role of IL-1 Inhibition in Patients Affected by Rheumatoid Arthritis and Diabetes.
    Ruscitti P; Cipriani P; Liakouli V; Carubbi F; Berardicurti O; Di Benedetto P; Ciccia F; Guggino G; Alvaro S; Triolo G; Giacomelli R
    Rev Recent Clin Trials; 2018; 13(3):210-214. PubMed ID: 29542422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.